impedimed

Impedimed's two blue sky opportunities

Livewire Exclusive
Livewire Exclusive
Livewire Markets

Impedimed presentation

Scott Power
Scott Power
Morgans

Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected

Canaccord Genuity
Canaccord Genuity
Stockbroker

Impedimed: Getting Significant Recognition In The Medical Community

Canaccord Genuity
Canaccord Genuity
Stockbroker

There are three small caps that look poised to end the year on a high even as the Santa Rally is starting to look like The Grinch.The so-called Santa Clause...

Brendon Lau
Vantage Point Partners

Lack of news flow has created an opportunity in IPD which has FDA approval and a full US Medicare reimbursement code that goes live on 01 January 2015 for its...

Canaccord Genuity
Canaccord Genuity
Stockbroker